Log in | Join Free | china | japan | germany

4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one

Request For Quotation
4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one Suppliers list
Company Name: Shanghai Sinch Parmaceuticals Tech. Co. Ltd.
Tel: +86-21-54098501
Email: sales@sinch.com.cn
Products Intro: Product Name:4-(2,5-difluorophenyl)-2,2-diMethyl-5-(4-(Methylsulfonyl)phenyl)furan-3(2H)-one
CAS:301692-24-0
Purity:0.95 Package:1g;5g;25g;50g;100g;1kg Remarks:SC00465
Company Name: guoyungurui  
Tel: 18162595016; 18162595016
Email: 3287908757@qq.com
Products Intro: Product Name:Vinflunine Impurity 9
CAS:301692-24-0
Purity:95%+HPLC Package:10mg;25mg;50mg;100mg;200mg
4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one Basic information
Product Name:4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one
Synonyms:4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one;4-(2,5-difluorophenyl)-5-(4-Methanesulfonylphenyl)-2,2-diMethyl-2,3-dihydrofuran-3-one;3(2H)-Furanone, 4-(2,5-difluorophenyl)-2,2-dimethyl-5-[4-(methylsulfonyl)phenyl]-;Vinflunine Impurity 9
CAS:301692-24-0
MF:C19H16F2O4S
MW:378.39
EINECS:
Product Categories:
Mol File:301692-24-0.mol
4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one Structure
4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one Chemical Properties
Boiling point 521.5±50.0 °C(Predicted)
density 1.339±0.06 g/cm3(Predicted)
Safety Information
MSDS Information
4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one Usage And Synthesis
4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one Preparation Products And Raw materials
Tag:4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one(301692-24-0) Related Product Information
Vecabrutinib 4-(2,4-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one 4-(5,5-dimethyl-4-oxo-3-m-tolyl-4,5-dihydrofuran-2-yl)benzenesulfonamide (3R,3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N,N-dimethyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide (3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide (3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-2-oxo[1,3′-bipiperidine]-4′-carboxamide (3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N,N-dimethyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide 4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylthio)phenyl)furan-3(2H)-one 4-(5,5-dimethyl-4-oxo-3-phenyl-4,5-dihydrofuran-2-yl)benzenesulfonamide (3S,3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide rel-(3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide [1,3'-Bipiperidine]-4'-carboxamide, 1'-(6-amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-2-oxo-, (3S,3'R,4'S)- 3(2H)-Furanone, 5-[4-[[(acetyloxy)methyl]thio]phenyl]-4-(3-fluorophenyl)-2,2-dimethyl- 4-(4-fluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one 2,2-dimethyl-5-(4-(methylthio)phenyl)-4-phenylfuran-3(2H)-one (3R,3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide 4-(3,4-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one (3R,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide